Work

Efficacy and safety of trastuzumab deruxtecan in HR-negative HER2-low advanced breast cancer: A real-world, retrospective study.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e15019

Authors: Mengqian Ni, Guorong Zou, Qingru Zhou, Lulu Zhang, Fei Xu, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin An

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, Panyu District Central Hospital, State Key Laboratory of Oncology in South China

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812103

FWCI:

Cites:

Cited by:

Related to: 10